(Q39589911)

English

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.

scientific article published on 9 July 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sebastian Giebel

1

object named as

S Giebel

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

M Labopin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

M Mohty

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

G J Mufti

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

D Niederwieser

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J J Cornelissen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J J W M Janssen

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

N Milpied

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

L Vindelov

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

E Petersen

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

R Arnold

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Bacigalupo

12

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

D Blaise

13

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

C Craddock

14

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A Nagler

15

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

F Frassoni

16

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

M Sadus-Wojciechowska

17

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

V Rocha

18

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

9 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

238-242

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Individual physician practice variation in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Variation in supportive care practices in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

21 January 2018

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.131

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2012.131

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Dimensions Publication ID

0 references

release_zvefcbymp5hinitmfvwsatzy2e

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39589911&oldid=2203003750"